Stocktoria
PALVELLA THERAPEUTICS, INC. PVLA
PALVELLA THERAPEUTICS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | -27.7% | -167.8% | -165.0% | -115.7% | -58.7% | -105.9% | -57.7% | -390.3% |
| Net margin | — | — | 43.7% | -128.5% | -145.6% | -127.0% | -55.0% | -91.9% | -69.8% | -391.0% |
| FCF margin | — | — | -32.4% | -235.4% | -27.4% | -165.8% | -118.7% | -9.5% | 189.1% | -256.4% |
| Return on assets | -70.0% | -19.8% | 247.6% | -34.8% | -29.8% | -35.5% | -18.1% | -18.9% | -17.0% | -65.0% |
| Return on equity | -149.1% | -27.8% | -25.1% | 35.5% | -90.1% | -120.0% | -49.6% | -67.0% | -153.2% | -90.4% |
| Current ratio | 5.20 | 7.33 | 3.20 | 2.01 | 2.52 | 3.42 | 4.26 | 2.82 | 1.96 | 3.90 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.